0.931
price up icon0.65%   0.006
after-market Dopo l'orario di chiusura: .93 -0.001 -0.11%
loading
Precedente Chiudi:
$0.925
Aprire:
$0.9
Volume 24 ore:
238.75K
Relative Volume:
0.59
Capitalizzazione di mercato:
$20.43M
Reddito:
-
Utile/perdita netta:
$-25.56M
Rapporto P/E:
-0.179
EPS:
-5.2
Flusso di cassa netto:
$-19.35M
1 W Prestazione:
-12.99%
1M Prestazione:
-10.48%
6M Prestazione:
-53.45%
1 anno Prestazione:
-77.65%
Intervallo 1D:
Value
$0.88
$0.96
Intervallo di 1 settimana:
Value
$0.88
$1.09
Portata 52W:
Value
$0.62
$7.50

Biovie Inc Stock (BIVI) Company Profile

Name
Nome
Biovie Inc
Name
Telefono
775-888-3162
Name
Indirizzo
680 W NYE LANE, CARSON CITY
Name
Dipendente
14
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
BIVI's Discussions on Twitter

Confronta BIVI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
BIVI
Biovie Inc
0.931 20.43M 0 -25.56M -19.35M -5.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Biovie Inc Stock (BIVI) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-07-22 Iniziato Cantor Fitzgerald Overweight
2021-01-15 Iniziato B. Riley Securities Buy

Biovie Inc Borsa (BIVI) Ultime notizie

pulisher
Jun 16, 2025

New to The Street’s Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - The Oklahoman

Jun 16, 2025
pulisher
Jun 16, 2025

New to The Street's Show #672 Airs Tonight on Fox Business Network at 10:30 PM EST - ACCESS Newswire

Jun 16, 2025
pulisher
Jun 16, 2025

BioVie and Liberty Star Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lubbock Avalanche-Journal

Jun 16, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Makes New Investment in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 14, 2025
pulisher
Jun 12, 2025

Millennium Management LLC Acquires Shares of 122,619 BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

Squarepoint Ops LLC Invests $28,000 in BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in BioVie LawsuitBIVI - ACCESS Newswire

Jun 07, 2025
pulisher
Jun 07, 2025

New to The Street Announces Upcoming Bloomberg Air Dates Featuring FLOKI, BioVie Pharmaceuticals, Beeline, Arrive AI, and Commercialville - The Oklahoman

Jun 07, 2025
pulisher
Jun 05, 2025

Northern Trust Corp Buys Shares of 16,878 BioVie Inc. (NASDAQ:BIVI) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 02, 2025

The Law Offices of Vincent Wong Remind BioVie Investors of a Lead Plaintiff Deadline of March 19, 2024 - marketscreener.com

Jun 02, 2025
pulisher
May 29, 2025

Investors' Lawsuit Against BioVie Moves to Evidence Review — Here's How to Recover Losses - TradingView

May 29, 2025
pulisher
May 28, 2025

Transcript : BioVie Inc.Special Call - marketscreener.com

May 28, 2025
pulisher
May 28, 2025

BioVie (NASDAQ:BIVI) Trading 1.9% Higher – Time to Buy? - Defense World

May 28, 2025
pulisher
May 18, 2025

FY2025 EPS Estimates for BioVie Raised by Analyst - Defense World

May 18, 2025
pulisher
May 15, 2025

BioVie Inc. Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BI - GuruFocus

May 15, 2025
pulisher
May 15, 2025

BioVie (BIVI) Begins Phase 2 Trial for Long COVID Treatment | BIVI Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

New Long COVID Treatment Hope: BioVie Launches Phase 2 Trial for 20M+ US Patients with Brain Fog - Stock Titan

May 15, 2025
pulisher
May 15, 2025

BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID - The Manila Times

May 15, 2025
pulisher
May 14, 2025

BioVie (BIVI) To Host Key Opinion Leader Event Discussing Parkin - GuruFocus

May 14, 2025
pulisher
May 14, 2025

BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of - GuruFocus

May 14, 2025
pulisher
May 14, 2025

BioVie to host KOL event on Phase 2 study of bezisterim - TipRanks

May 14, 2025
pulisher
May 14, 2025

BioVie Inc. to Host Virtual KOL Event Discussing Parkinson’s Disease and Update on Phase 2 SUNRISE-PD Trial for Bezisterim - Nasdaq

May 14, 2025
pulisher
May 14, 2025

BioVie to Host Virtual KOL Event to Discuss the Phase 2 - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Biovie Inc. to Host Virtual Kol Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Critical Survey: Coya Therapeutics (NASDAQ:COYA) vs. BioVie (NASDAQ:BIVI) - Defense World

May 14, 2025
pulisher
May 12, 2025

BIOVIE Earnings Results: $BIVI Reports Quarterly Earnings - Nasdaq

May 12, 2025
pulisher
May 12, 2025

BIOVIE INC. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Lost Money on BioVie Inc.(BIVI)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - ACCESS Newswire

May 12, 2025
pulisher
May 11, 2025

BioVie (BIVI) to Release Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 10, 2025

Investors who lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

BioVie Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before March 19, 2024 to Discuss Your RightsBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Levi & Korsinsky Notifies BioVie Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Investors who lost money on BioVie Inc.(BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Levi & Korsinsky Reminds BioVie Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024BIVI - ACCESS Newswire

May 10, 2025
pulisher
May 09, 2025

Shareholders that lost money on BioVie Inc.(BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

INVESTOR ALERT: Potential Recovery for BioVie Inc. (BIVI) Investors Affected by Stock DropLevi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire

May 09, 2025
pulisher
May 09, 2025

Shareholders that lost money on BioVie Inc. (BIVI) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 09, 2025
pulisher
May 08, 2025

Shareholders that lost money on BioVie Inc. (BIVI) should contact Levi & Korsinsky about pending Class ActionBIVI - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against BioVie Inc. (BIVI) And Encourages Investors to Reach Out - ACCESS Newswire

May 08, 2025
pulisher
May 07, 2025

BioVie to Present Rationale and Design of Phase 2 - GlobeNewswire

May 07, 2025
pulisher
May 07, 2025

BioVie (BIVI) Showcases Parkinson's Trial at Global Conference | BIVI Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Market Insights: BioVie Inc (BIVI)’s Notable Gain of 1.75, Closing at 1.16 - DWinneX

May 07, 2025

Biovie Inc Azioni (BIVI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):